Gary Charles Robb insider trades
Open-market stock purchases and sales by Gary Charles Robb, Chief Business Officer at Corcept Therapeutics Inc, from SEC Form 4 filings since Sep 1, 2011.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Jun 2, 2026 | CORT Corcept Therapeutics Inc | Sold (not open market) | $25.2K |
| Jun 1, 2026 | CORT Corcept Therapeutics Inc | Bought (not open market) | — |
| May 13, 2026 | CORT Corcept Therapeutics Inc | Sold (not open market) | — |
| May 13, 2026 | CORT Corcept Therapeutics Inc | Bought (not open market) | — |
| Mar 3, 2026 | CORT Corcept Therapeutics Inc | Sold (not open market) | $4.4K |
| Mar 2, 2026 | CORT Corcept Therapeutics Inc | Bought (not open market) | — |
| Feb 27, 2026 | CORT Corcept Therapeutics Inc | Bought (not open market) | — |
| Dec 24, 2025 | CORT Corcept Therapeutics Inc | Sold (not open market) | $6.7M |
| Dec 24, 2025 | CORT Corcept Therapeutics Inc | Bought (not open market) | — |
| Dec 2, 2025 | CORT Corcept Therapeutics Inc | Sold (not open market) | $11.8K |
| Dec 1, 2025 | CORT Corcept Therapeutics Inc | Bought (not open market) | — |
Companies traded
- CORT Corcept Therapeutics Inc: 1 buy, 33 sales, last Jun 2, 2026